Discovery and Characterization of a Class of Pyrazole Inhibitors of Bacterial Undecaprenyl Pyrophosphate Synthase

Journal of Medicinal Chemistry
2016.0

Abstract

Undecaprenyl pyrophosphate synthase (UppS) is an essential enzyme in bacterial cell wall synthesis. Here we report the discovery of Staphylococcus aureus UppS inhibitors from an Encoded Library Technology screen and demonstrate binding to the hydrophobic substrate site through cocrystallography studies. The use of bacterial strains with regulated uppS expression and inhibitor resistant mutant studies confirmed that the whole cell activity was the result of UppS inhibition, validating UppS as a druggable antibacterial target.

Knowledge Graph

Similar Paper

Discovery and Characterization of a Class of Pyrazole Inhibitors of Bacterial Undecaprenyl Pyrophosphate Synthase
Journal of Medicinal Chemistry 2016.0
Lipophilic efficient phenylthiazoles with potent undecaprenyl pyrophosphatase inhibitory activity
European Journal of Medicinal Chemistry 2019.0
Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphatase
Bioorganic & Medicinal Chemistry 2014.0
Inhibitors of bacterial N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE) and demonstration of in vitro antimicrobial activity
Bioorganic & Medicinal Chemistry Letters 2009.0
2-Phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives as new inhibitors of bacterial cell wall biosynthesis
Bioorganic & Medicinal Chemistry Letters 2003.0
Spirohexalines, new inhibitors of bacterial undecaprenyl pyrophosphate synthase, produced by Penicillium brasilianum FKI-3368
The Journal of Antibiotics 2013.0
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design
ACS Medicinal Chemistry Letters 2016.0
Total Synthesis of Laspartomycin C and Characterization of Its Antibacterial Mechanism of Action
Journal of Medicinal Chemistry 2016.0
A MurF Inhibitor That Disrupts Cell Wall Biosynthesis in Escherichia coli
Antimicrobial Agents and Chemotherapy 2007.0
Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis
Journal of Medicinal Chemistry 2018.0